Skip to content Skip to contact
Global Vox Populi

Top Market Research Companies in Brazil Specializing in Healthcare

Compare top healthcare market research companies in Brazil for 2026. Get expert insights on verified HCP panels, patient data, and regulatory compliance.

Quick answer

For syndicated longitudinal market data, choose IQVIA or NielsenIQ. For high-incidence consumer health tracking, select Kantar or Ipsos. For specialized, account-level primary research and hard-to-reach HCP or patient segments, choose Global Vox Populi or BioNixus.

Selecting among healthcare market research companies in Brazil requires balancing the need for broad market intelligence with the precision of primary clinical and patient data. Pharmaceutical and medical technology firms must work through a complex environment characterized by the dual-tier public-private health system and varying regulatory demands, making the choice of research partner a significant decision for commercial strategy.

This assessment examines established global providers and specialized research firms that possess the capacity to execute studies in Brazil. Whether you require national market measurement or granular, account-level insights into physician behavior, understanding the distinct research approach of each agency is necessary to align your procurement with specific project objectives and data quality standards.

Top Market Research Companies in Brazil Specializing in Healthcare: rankings and scores

Exhibit 1: Ranking and weighted score (out of 100)

RankProviderBest forWeighted score
1IQVIALarge-scale pharmaceutical market measurement and clinical data88.0
2Global Vox PopuliSpecialized healthcare professional and patient primary research87.5
3BioNixusAccount-level and SKU-level primary pharmaceutical research85.0
4KantarBrand equity tracking and consumer health communication research82.0
5IpsosPublic health and patient journey research79.0
6NielsenIQRetail measurement and consumer health analytics76.0
7Euromonitor InternationalStrategic market sizing and competitive environment assessment64.5

Exhibit 2: Provider comparison

ProviderAudience typesVerification methodCertificationsPricing modelPanel size and sourceMinimum project
IQVIAPhysicians, pharmacists, and wholesalersNot stated on pages reviewedNot stated on pages reviewedNot publishedNot publishedNot published
Global Vox PopuliPhysicians, patients, nurses, payers, and caregiversLicense validation, registry checks, and rolling re-validationISO 9001, ISO 20252, ISO/IEC 27001, HIPAA compliant; follows ESOMAR, Insights Association and BHBIA guidelinesProject quote100,600 healthcare professionals; 1,054,165 patient profiles; 69,723 nurses and allied health professionals (in Brazil; Global Vox Populi panel records, Oct 2026)Not published
BioNixusPhysicians, payers, and hospital decision-makersIdentity and quality checks on every waveNot stated on pages reviewedProject quoteNot publishedNot published
KantarConsumers and patientsAI-enabled panel fraud detectionNot stated on pages reviewedProject quoteNot publishedNot published
IpsosPatients, physicians, and citizensAuthenticated proprietary panelistsNot stated on pages reviewedProject quoteNot publishedNot published
NielsenIQRetailers and consumer health shoppersNot stated on pages reviewedNot stated on pages reviewedSubscriptionNot publishedNot published
Euromonitor InternationalCorporate strategy and marketing teamsNot stated on pages reviewedNot stated on pages reviewedSubscriptionNot publishedNot published

Exhibit 3: Capability matrix

ProviderQuantitativeQualitativeOwn panels / sampleHealthcareB2BMulti-country
IQVIA●––●––
Global Vox Populi●●●●●●
BioNixus●●–●––
Kantar●●●●–●
Ipsos●●●●–●
NielsenIQ●–●●––
Euromonitor International–––●–●

Table data from each provider’s own website and public sources, reviewed October 2026. “Not published” means the provider does not state it publicly. ● highlighted in the provider’s own materials; – not highlighted (it may still offer it).

How we scored these providers

Score providers based on their capability to deliver accurate, compliant, and actionable intelligence within the specific regulatory and demographic constraints of the Brazilian market.

CriterionWeightWhat it means here
Industry Expertise20This measures the depth of experience in the healthcare sector, specifically regarding the Brazilian Unified Health System and private insurance dynamics. A high-scoring firm demonstrates specialized knowledge of local pharmaceutical regulation, market access, and the unique behaviors of Brazilian clinicians, payers, and patient demographics across diverse therapeutic areas.
Compliance, Certifications and Security20This evaluates adherence to international standards like ISO 20252 and ISO 27001, alongside local data protection laws. In healthcare, it includes rigorous protocols for adverse event reporting and HIPAA-equivalent privacy measures. High-scoring firms provide transparent documentation on consent, ethics, and secure data handling for sensitive medical information.
Target Audience Reach15This assesses the ability to access specific medical and patient groups, including low-incidence specialists and rare-disease patients. It considers panel size, the depth of profiling, and the use of verified professional registries rather than open-access sampling to protect the data represents the target population accurately.
Research Quality10This focuses on the rigour of study design, questionnaire development, and fieldwork management. Good quality involves active measures to prevent fraud, such as straight-lining detection and identity validation, making sure that the final insights are derived from authentic, high-quality responses that support valid commercial decision-making.
Market Presence10How established the provider is in this market: whether it appears repeatedly in what already ranks on Google for this search, and its size by headcount. Calculated by the script from the search record and company size, not judged by the writer.
Methodological Breadth10This measures the variety of available research tools, from traditional quantitative surveys and CATI to qualitative methods like focus groups and ethnography. The ability to deploy advanced analytical techniques such as conjoint analysis, MaxDiff, or patient journey mapping is essential for complex pharmaceutical and medical technology projects.
Analytical Capability5This evaluates the provider's capacity to synthesize raw data into clear, business-focused recommendations. A strong provider moves beyond descriptive reporting, offering strategic synthesis, segmentation, and actionable insights that help brand managers and commercial directors make informed decisions regarding launch, market share, and portfolio strategy.
Client Service and Speed5This assesses responsiveness and project management efficiency throughout the research cycle. High-scoring firms provide clear communication, rapid turnaround for proposals and fieldwork, and proactive problem-solving to manage the complexities of local data collection in Brazil without compromising the integrity of the study.
Pricing and Feasibility Transparency5This measures the clarity of project scope, timelines, and cost structures. Reliable firms provide realistic feasibility assessments for target audiences up front and maintain transparency regarding what can be achieved, helping buyers manage project expectations and budget allocations effectively without hidden costs or delays.

Why these weights. Healthcare and pharma research needs sector knowledge and strict compliance (adverse event reporting, HIPAA, health-data rules), so both lead with 20. Access to physicians, patients and payers follows (15), then design rigour and methods (10 each); analysis, service and pricing transparency (5 each) complete the score. Market presence (10) gives credit to providers that are established in this market: those that appear repeatedly in what already ranks for this search, and larger firms.

Each provider is scored 1 to 10 on every criterion from the evidence listed beside it (its own website and public sources, with the date reviewed). Weighted score = sum of score × weight ÷ 10, out of 100. Read the full scoring methodology. Global Vox Populi answers to ESOMAR’s 37 Questions for buyers of online samples show how Global Vox Populi recruits, verifies and protects its own panels.

Provider profiles: market research companies in Brazil

01

IQVIA: best for large-scale pharmaceutical market measurement and clinical data

iqvia.com

88.0out of 100Rank 1 of 7
IQVIA homepage
IQVIA homepage, October 2026

Strongest fitA pharmaceutical company requiring large-scale market data and real-world evidence for commercial planning.

IQVIA is a global provider of data, technology, and analytics for the life sciences industry. In Brazil, the firm maintains a significant presence, supporting pharmaceutical and medical device companies with market intelligence, prescription audits, and clinical development solutions.

Their expertise spans the entire asset lifecycle, from clinical trial site identification to commercial execution. They use vast proprietary databases to help organizations assess market opportunities, monitor performance, and optimize therapeutic strategies within the complex Brazilian healthcare environment.

Scorecard: 88.0 out of 100
CriterionWeightScoreEvidence and date
Industry Expertise2010/10iqvia.com (4 pages reviewed), Oct 2026
Compliance, Certifications and Security209/10iqvia.com (4 pages reviewed), Oct 2026
Target Audience Reach158/10iqvia.com (4 pages reviewed), Oct 2026
Research Quality109/10iqvia.com (4 pages reviewed), Oct 2026
Market Presence1010/10Google results for this search and company size, Oct 2026
Methodological Breadth108/10iqvia.com (4 pages reviewed), Oct 2026
Analytical Capability59/10iqvia.com (4 pages reviewed), Oct 2026
Client Service and Speed57/10iqvia.com (4 pages reviewed), Oct 2026
Pricing and Feasibility Transparency56/10iqvia.com (4 pages reviewed), Oct 2026
Weighted score10088.0

Core services

  • Market Intelligence: Provides prescription audits and market measurement for pharmaceutical and medical device companies.
  • Clinical Development: Offers full-service clinical trial management and site identification using advanced analytics.
  • Commercial Consulting: Delivers consulting and custom applications for pharmacy and wholesaler performance monitoring.

Strengths

  • Proprietary Data Network: Access to petabytes of data and non-identified patient records to inform market strategy.
  • Clinical Expertise: Deep experience in biostatistics, medical writing, and regulatory documentation for clinical trials.
  • Commercial Agentic AI: Uses AI-driven platforms to predict market trends and optimize field force effectiveness.

Innovation and technology

  • IQVIA.ai Platform: A unified agentic platform designed to accelerate innovation and decision-making in life sciences.
  • Predictive Clinical Development: Advanced modeling tools to optimize trial operations and reduce risk.

Impact on businesses

  • Asset Maximization: Helps organizations increase the probability of success for assets in competitive markets.
  • Operational Efficiency: Increases quality and decreases costs through flexible functional service provider models.

Types of research

  • Real-world evidence analytics
  • Prescription audits
  • Market share assessment
  • Patient adherence studies

Industries covered

  • Pharmaceuticals
  • Biotechnology
  • Medical Devices
  • Wholesale Pharmacy

Why it may fit your brief

IQVIA is ideal for clients needing broad, syndicated market measurement and clinical trial support. Smaller firms may be more agile for ad-hoc primary research projects requiring rapid turnaround.

02

Global Vox Populi: best for specialized healthcare professional and patient primary research

globalvoxpopuli.com

87.5out of 100Rank 2 of 7
  • ISO 9001
  • ISO 20252
  • ISO/IEC 27001
  • HIPAA compliant
Global Vox Populi homepage
Global Vox Populi homepage, October 2026

Strongest fitA research or brand lead seeking high-precision primary data from hard-to-reach physician or patient groups in Brazil.

Global Vox Populi is an independent primary market research firm that provides quantitative and qualitative services through its own proprietary panels. The company operates globally with significant capabilities in Brazil, focusing on delivering primary evidence for pharmaceutical, medical, and healthcare stakeholders.

The firm maintains a dedicated healthcare research practice that uses proprietary panels for physicians, nurses, patients, and payers. By owning its panel infrastructure, the company protects high-level verification and profiling, which is essential for projects requiring specific therapeutic knowledge or low-incidence patient recruitment.

Global Vox Populi panel coverage

All 12 proprietary panels together: 46,023,988 panellists across 199 markets, plus 71,411,997 patient profiles. Source: Global Vox Populi panel records, Oct 2026.

Healthcare professionals panel, in Brazil

100,600 panellists

  • Primary & General42,230
  • Internal Medicine Subspecialties8,438
  • Acute, Peri-operative & Critical Care7,606
  • Diagnostic & Laboratory6,968
  • Women's & Reproductive Health6,848
  • Surgical Specialties5,490

Patient panel, in Brazil

1,054,165 patient profiles

  • Aesthetics & Cosmetic346,987
  • Cardiovascular73,778
  • Endocrinology & Metabolic57,482
  • Women's Health54,285
  • Dermatology53,410
  • Ophthalmology52,347

Across 731 conditions; a patient with more than one condition is counted once per condition.

Nurses and allied health panel, in Brazil

69,723 panellists

  • Registered Nurses24,111
  • Advanced Practice Nurses1,528
  • Licensed / Practical / Enrolled Nurses4,443
  • Nursing Support (Aides / HCAs)2,600
  • Midwives2,156
  • Pharmacists & Pharmacy Techs5,140
Scorecard: 87.5 out of 100
CriterionWeightScoreEvidence and date
Industry Expertise2010/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Compliance, Certifications and Security2010/10ISO certificates and HIPAA policy, Oct 2026
Target Audience Reach159/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Research Quality1010/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Market Presence102/10Google results for this search and company size, Oct 2026
Methodological Breadth109/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Analytical Capability58/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Client Service and Speed59/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Pricing and Feasibility Transparency59/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Weighted score10087.5

Core services

  • Primary Research Execution: Full-service management of quantitative and qualitative projects using proprietary panels.
  • Healthcare Professional Access: Targeted recruitment of physicians across 70+ specialties and allied health professionals.
  • Patient and Caregiver Studies: Direct access to patient panels across diverse therapeutic areas for journey mapping.

Strengths

Innovation and technology

  • Data Integrity Technology: Uses device fingerprinting, geo-checks, and automated fraud detection to protect respondent authenticity.
  • Proprietary Survey Platform: Surveys are hosted on an internal platform with advanced mobile and WhatsApp-assisted survey capabilities.

Impact on businesses

  • Commercial Strategy Support: Provides the primary evidence required for launch readiness, market access, and portfolio priority decisions.
  • Clinical Insight Generation: Enables pharma companies to map unmet medical needs and treatment pathways through expert and patient feedback.

Types of research

  • Focus groups and IDIs
  • Online and mobile surveys
  • Brand tracking studies
  • Ethnographic research
  • Expert KOL interviews

Industries covered

  • Pharmaceuticals
  • Medical Technology
  • Healthcare Providers
  • Consumer Health

Why it may fit your brief

The firm is built for primary research where accuracy and specific segmentation are required, rather than syndicated market totals. It is the appropriate choice for bespoke studies where the target audience is not available via standard open panels.

Request a quoteView case studies

03

BioNixus: best for account-level and SKU-level primary pharmaceutical research

bionixus.com

85.0out of 100Rank 3 of 7
BioNixus homepage
BioNixus homepage, October 2026

Strongest fitA pharmaceutical commercial team needing granular, account-level data to supplement syndicated subscriptions.

BioNixus is a global primary market research firm that specializes in account-level and SKU-level brand versus competitor data. They provide research services to pharmaceutical and consumer health teams across 48 countries, including Brazil.

The company focuses on filling the gaps left by syndicated subscriptions, offering primary fieldwork that captures sub-account, traditional trade, and local market dynamics. They provide actionable decision packs designed for marketing and commercial teams to inform launch and share plans.

Scorecard: 85.0 out of 100
CriterionWeightScoreEvidence and date
Industry Expertise209/10bionixus.com (6 pages reviewed), Oct 2026
Compliance, Certifications and Security208/10bionixus.com (6 pages reviewed), Oct 2026
Target Audience Reach159/10bionixus.com (6 pages reviewed), Oct 2026
Research Quality109/10bionixus.com (6 pages reviewed), Oct 2026
Market Presence107/10Google results for this search and company size, Oct 2026
Methodological Breadth109/10bionixus.com (6 pages reviewed), Oct 2026
Analytical Capability59/10bionixus.com (6 pages reviewed), Oct 2026
Client Service and Speed58/10bionixus.com (6 pages reviewed), Oct 2026
Pricing and Feasibility Transparency58/10bionixus.com (6 pages reviewed), Oct 2026
Weighted score10085.0

Core services

  • Primary Healthcare Research: Physician and payer surveys including conjoint and MaxDiff methodologies.
  • Account-Level Intelligence: Provides brand vs competitor data at the hospital, department, and SKU level.
  • Strategic Consulting: Assists with market sizing, pricing, and reimbursement dossiers.

Strengths

  • Granular Data Breakdown: Captures sub-account and traditional trade data that syndicated feeds often miss.
  • Healthcare Specialization: Deep experience in pharmaceutical market access, HTA dossiers, and launch readiness.
  • Fast Turnaround: Proposals are provided within 48 hours of a brief to accelerate project initiation.

Innovation and technology

  • Decision-Pack Output: Delivers findings ready for commercial leadership rather than raw dashboard exports.
  • Advanced Methodologies: Uses Conjoint, MaxDiff, and discrete choice experiments for statistically solid data.

Impact on businesses

  • Commercial Precision: Enables teams to refine share plans with account-specific evidence.
  • Launch Readiness: Informs launch and access strategies with direct payer and physician feedback.

Types of research

  • Physician surveys
  • KOL interviews
  • Advisory boards
  • Patient journey mapping

Industries covered

  • Pharmaceuticals
  • Life Sciences
  • Healthcare

Why it may fit your brief

BioNixus is ideal for primary research on specific commercial questions. For broad market monitoring or consumer-focused tracking, other providers may be more cost-effective.

04

Kantar: best for brand equity tracking and consumer health communication research

kantar.com

82.0out of 100Rank 4 of 7
Kantar homepage
Kantar homepage, October 2026

Strongest fitA consumer health company focused on brand health, ad effectiveness, and consumer behavior.

Kantar delivers market research and data analytics with a focus on brand growth and consumer understanding. In Brazil, their healthcare practice is rooted in OTC brand tracking, patient surveys, and communication research.

By using their consumer panel infrastructure, Kantar helps healthcare brands understand evolving behaviors and market dynamics. They combine survey data with behavioral science frameworks to provide actionable insights into brand salience and consumer needs.

Scorecard: 82.0 out of 100
CriterionWeightScoreEvidence and date
Industry Expertise208/10kantar.com (4 pages reviewed), Oct 2026
Compliance, Certifications and Security208/10kantar.com (4 pages reviewed), Oct 2026
Target Audience Reach158/10kantar.com (4 pages reviewed), Oct 2026
Research Quality109/10kantar.com (4 pages reviewed), Oct 2026
Market Presence1010/10Google results for this search and company size, Oct 2026
Methodological Breadth108/10kantar.com (4 pages reviewed), Oct 2026
Analytical Capability58/10kantar.com (4 pages reviewed), Oct 2026
Client Service and Speed57/10kantar.com (4 pages reviewed), Oct 2026
Pricing and Feasibility Transparency57/10kantar.com (4 pages reviewed), Oct 2026
Weighted score10082.0

Core services

  • Brand Equity Tracking: Measures brand strength and valuation through comprehensive consumer studies.
  • Survey Solutions: Provides custom and DIY survey tools for gathering consumer feedback.
  • Digital Audience Activation: Connects research segments to ad platforms for targeted media activation.

Strengths

  • Global Panel Reach: Operates proprietary premium panels across over 100 markets for reliable data collection.
  • Advanced Quality Assurance: Uses AI-driven tools to detect fraud and protect respondent quality.
  • Integration Capabilities: Matches third-party data with survey respondents for a holistic view of the audience.

Innovation and technology

  • Qubed AI: Proprietary technology that uses neural networks to identify and block fraudulent activity.
  • Kantar Marketplace: An agile research platform combining survey products with powerful analytics.

Impact on businesses

  • Brand Growth: Helps brands build profitable and sustainable market positions.
  • Effective Communication: Optimizes creative assets to increase attention and ROI across media channels.

Types of research

  • Brand health tracking
  • Qualitative consumer research
  • Omnibus surveys
  • Ad testing

Industries covered

  • Consumer Health
  • OTC Pharmaceuticals
  • Media
  • Retail

Why it may fit your brief

Kantar is excellent for consumer-facing health brands. For highly technical or regulatory-heavy pharmaceutical projects, specialized research firms may offer deeper clinical alignment.

05

Ipsos: best for public health and patient journey research

ipsos.com

79.0out of 100Rank 5 of 7
Ipsos homepage
Ipsos homepage, October 2026

Strongest fitA pharmaceutical or public health organization needing deep insights into patient experiences and system perceptions.

Ipsos is a global market research company that provides comprehensive healthcare insights. In Brazil, they use local expertise to study patient journeys, physician perceptions, and public health system dynamics.

The company uses a mix of survey data, social media monitoring, and qualitative research to provide actionable truth. Their work helps clients work through the unique complexities of the Brazilian healthcare system, focusing on society, markets, and people.

Scorecard: 79.0 out of 100
CriterionWeightScoreEvidence and date
Industry Expertise209/10ipsos.com (4 pages reviewed), Oct 2026
Compliance, Certifications and Security208/10ipsos.com (4 pages reviewed), Oct 2026
Target Audience Reach158/10ipsos.com (4 pages reviewed), Oct 2026
Research Quality108/10ipsos.com (4 pages reviewed), Oct 2026
Market Presence106/10Google results for this search and company size, Oct 2026
Methodological Breadth108/10ipsos.com (4 pages reviewed), Oct 2026
Analytical Capability58/10ipsos.com (4 pages reviewed), Oct 2026
Client Service and Speed57/10ipsos.com (4 pages reviewed), Oct 2026
Pricing and Feasibility Transparency57/10ipsos.com (4 pages reviewed), Oct 2026
Weighted score10079.0

Core services

  • Healthcare Research: Tracks patient and physician perceptions of healthcare quality and system issues.
  • Brand Health Tracking: Provides longitudinal tracking of brand performance and market understanding.
  • Qualitative Research: Uses in-depth qualitative methods to uncover deep customer and patient insights.

Strengths

  • Global Trends Expertise: Publishes regular global reports on health concerns and system satisfaction.
  • Proprietary Panel Network: Access to a large network of authenticated panelists for reliable data.
  • Integrated Solutions: Combines survey data with social media and qualitative research for deeper understanding.

Innovation and technology

  • AI Insights: Uses AI to analyze data and deliver faster insights for clients.
  • Ipsos UU: Specialized qualitative research division for exploring human experiences.

Impact on businesses

  • Smarter Decisions: Helps clients act faster and with more confidence based on reliable information.
  • True Understanding: Provides a deep understanding of market trends and societal attitudes.

Types of research

  • Patient journey studies
  • Physician surveys
  • Public opinion polls
  • Brand health tracking

Industries covered

  • Pharmaceuticals
  • Public Health
  • Consumer Health
  • Healthcare Systems

Why it may fit your brief

Ipsos is a strong partner for patient-centric and public health research. For hyper-local, account-specific pharmaceutical sales data, a more specialized commercial research firm may be better suited.

06

NielsenIQ: best for retail measurement and consumer health analytics

nielseniq.com

76.0out of 100Rank 6 of 7
NielsenIQ homepage
NielsenIQ homepage, October 2026

Strongest fitA consumer health brand needing retail sell-out data and pharmacy channel insights.

NielsenIQ provides comprehensive views of consumer buying behavior across retail and e-commerce channels. In Brazil, their healthcare practice focuses on pharmacy sell-out measurement, retail analytics, and tracking consumer health trends.

The company supports manufacturers and retailers by providing data on market share, pricing, and promotional effectiveness. Their solutions enable businesses to track product performance in the competitive Brazilian pharmacy environment and identify growth opportunities through detailed consumer intelligence.

Scorecard: 76.0 out of 100
CriterionWeightScoreEvidence and date
Industry Expertise208/10nielseniq.com (4 pages reviewed), Oct 2026
Compliance, Certifications and Security207/10nielseniq.com (4 pages reviewed), Oct 2026
Target Audience Reach157/10nielseniq.com (4 pages reviewed), Oct 2026
Research Quality108/10nielseniq.com (4 pages reviewed), Oct 2026
Market Presence1010/10Google results for this search and company size, Oct 2026
Methodological Breadth107/10nielseniq.com (4 pages reviewed), Oct 2026
Analytical Capability58/10nielseniq.com (4 pages reviewed), Oct 2026
Client Service and Speed57/10nielseniq.com (4 pages reviewed), Oct 2026
Pricing and Feasibility Transparency56/10nielseniq.com (4 pages reviewed), Oct 2026
Weighted score10076.0

Core services

  • Retail Measurement: Tracks sales performance and market share across pharmacy and retail channels.
  • Consumer Analytics: Uses representative panels to understand purchasing behavior and brand loyalty.
  • Pricing and Promotion: Provides insights to maximize profitability and optimize trade spend strategies.

Strengths

  • Comprehensive Data Coverage: Measures consumer transactions to deliver detailed data sets on product performance.
  • Omnichannel Insights: Tracks sales and performance across both brick-and-mortar retail and digital commerce.
  • Predictive Analytics: Uses market-tested insights to help brands forecast demand and accelerate market entry.

Innovation and technology

  • Full View Platform: A cloud-based platform for accessing detailed consumer and retail data anytime.
  • Connect Express Go: A mobile application for visualizing category management and sales data.

Impact on businesses

  • Growth Identification: Helps businesses identify new trends and potential market disruptors.
  • Decision Support: Enables leaders to make data-driven decisions on pricing, promotion, and product strategy.

Types of research

  • Retail sell-out measurement
  • Consumer panel research
  • Market share quantification
  • Trend analysis

Industries covered

  • Consumer Health
  • Retail Pharmacy
  • CPG
  • Medical Products

Why it may fit your brief

NielsenIQ is well-suited for high-volume retail and consumer health data. For primary research involving medical professionals or complex clinical questions, a more specialized healthcare firm is often preferred.

07

Euromonitor International: best for strategic market sizing and competitive environment assessment

euromonitor.com

64.5out of 100Rank 7 of 7

Strongest fitA corporate strategy lead needing broad market sizing and competitor intelligence in Brazil.

Euromonitor International provides syndicated market intelligence and strategic research. In Brazil, their healthcare practice covers consumer health, pharmaceuticals, and medical equipment markets.

The firm supports clients with market sizing, competitive environment assessments, and long-term forecasts. Their research helps brands plan corporate strategy based on solid local and global data sets, providing a clear view of market dynamics and growth potential.

Scorecard: 64.5 out of 100
CriterionWeightScoreEvidence and date
Industry Expertise207/10Search results and industry sources, Oct 2026
Compliance, Certifications and Security206/10Search results and industry sources, Oct 2026
Target Audience Reach155/10Search results and industry sources, Oct 2026
Research Quality107/10Search results and industry sources, Oct 2026
Market Presence109/10Google results for this search and company size, Oct 2026
Methodological Breadth106/10Search results and industry sources, Oct 2026
Analytical Capability57/10Search results and industry sources, Oct 2026
Client Service and Speed56/10Search results and industry sources, Oct 2026
Pricing and Feasibility Transparency55/10Search results and industry sources, Oct 2026
Weighted score10064.5

Core services

  • Market Intelligence: Provides detailed reports on industry trends and competitive performance.
  • Strategic Consulting: Offers forecasting and market sizing to support long-term corporate planning.
  • Competitive Analysis: Assesses the environment of pharmaceutical and medical device markets.

Strengths

  • Global Research Network: Uses in-country analysts to provide regional intelligence and data.
  • Strategic Depth: Focuses on providing the high-level intelligence needed for corporate strategy.

Innovation and technology

  • Passport Database: A research platform that integrates industry data with strategic analysis.

Impact on businesses

  • Informed Strategy: Enables leadership teams to make decisions on market entry and portfolio management.

Types of research

  • Market sizing
  • Competitive environment assessment
  • Strategic forecasting
  • Industry trend analysis

Industries covered

  • Pharmaceuticals
  • Consumer Health
  • Medical Equipment

Why it may fit your brief

Euromonitor is effective for high-level strategic planning. It is less suited for projects requiring primary field research or specific physician feedback.

How HCP and patient verification actually works in Brazil

Protect every healthcare professional and patient in your study is verified through license checks and multi-factor authentication rather than open-internet opt-ins.

Professional License Verification

For physician and nurse panels, providers should cross-reference member profiles against active medical or nursing registration databases. In Brazil, this involves checking against local professional council records. Always request the specific methodology used for this verification, as relying on self-declaration is a primary source of data degradation in pharmaceutical market research.

Patient Identity Authentication

Patient samples must be verified through methods beyond simple self-reporting. This includes medical record verification for specific conditions or third-party validation of patient registries. High-quality firms use double opt-in processes and identity fingerprinting to make sure that patients are legitimate and represent the target therapeutic area, avoiding the common pitfall of professional survey participants posing as patients.

Fraud and Bot Detection

The research platform must employ technical safeguards to protect data integrity. This includes IP geo-checking to make sure respondents are located in Brazil, device fingerprinting to prevent duplicate completions, and the use of trap questions or straight-lining detection to identify non-attentive participants. Ask for a report on the firm's anti-fraud protocols and how they handle the removal of fraudulent completes prior to data delivery.

Consent and Privacy Compliance

Data collection must adhere to local data protection laws and international healthcare privacy standards. Verify that the provider maintains granular, revocable consent from all respondents and handles medical information with the necessary security measures. Proof of compliance should be available through relevant ISO certifications and explicit adherence to industry codes like those from ESOMAR or equivalent bodies.

How to choose the right provider in Brazil

Use this checklist to match your research objectives with the appropriate service provider structure.

  • Define project scope: Determine if you need broad market totals or deep primary insights. Syndicated providers are best for market sizing, while primary firms are better for bespoke physician and patient studies.
  • Audit panel quality: Ask how the provider recruits and verifies their panels. Prioritize firms that use proprietary, verified registries over those relying on open-market, rented samples.
  • Assess regulatory capability: Confirm the provider understands local healthcare regulations in Brazil. Make sure they have clear protocols for adverse event reporting if your study involves drug feedback.
  • Evaluate local expertise: Make sure the agency has a dedicated team in Brazil that understands the local healthcare system. A firm with local presence is better equipped to handle cultural nuances and field management.
  • Review data outputs: Check if the firm provides raw data, dashboards, or strategic decision packs. Choose based on whether your team needs data for analysis or direct inputs for commercial strategy.

Questions to ask before you commission

  1. What is your specific methodology for verifying the medical credentials of the physicians in your Brazilian panel?
  2. How do you handle adverse event reporting in compliance with Brazilian pharmaceutical regulations during primary research?
  3. Can you provide a feasibility report for our specific target audience in Brazil before we commit to a full project?
  4. What specific measures do you take to prevent professional survey participants from infiltrating your patient or HCP panels?
  5. How do your account-level research capabilities differ from the data provided by syndicated market subscriptions?
  6. What is your turnaround time for a standard quantitative physician survey in the Brazilian market?

Common pitfalls to avoid

  • Relying on open panels: Using general market research panels for healthcare studies often leads to low-quality data and non-representative samples of medical professionals.
  • Ignoring local regulation: Failing to check for local adverse event reporting protocols can lead to significant compliance risks during pharmaceutical research.
  • Overestimating feasibility: Assuming a provider can reach niche specialists or rare-disease patients without a formal feasibility check often leads to project delays.
  • Confusing data with insight: Purchasing raw market data without the necessary analytical support to interpret it for your specific commercial decision can lead to wasted budget.

What a feasibility check should include

A reliable feasibility assessment must be based on the provider's actual panel data rather than general industry estimates.

Audience incidence rates

The provider must accurately report the percentage of their panel that meets your specific criteria, such as specialty, prescribing volume, or patient condition.

Panel availability

Check if the required number of respondents are active and reachable within your project timeframe, considering the high demand for certain specialist groups.

Geographic coverage

Protect the feasibility covers the necessary regions in Brazil if your study requires local or specific regional representation.

Language and cultural fit

Confirm that the survey instrument can be effectively translated and adapted for the target audience to protect high completion quality.

Conclusion

Choosing the right research partner for healthcare market research companies in Brazil depends on the nature of your commercial challenge. For broad market intelligence, syndicated providers offer essential scale and historical data. However, for primary research that directly informs product launches or clinical strategy, partnering with a firm that owns its proprietary panels and offers specialized healthcare expertise is critical.

Use this scorecard to evaluate providers based on their ability to deliver verified, compliant data. Prioritize firms that demonstrate rigorous verification of medical professionals and patients, as this is the most reliable predictor of high-quality, actionable insights. By aligning your specific research needs with the strengths of these agencies, you can make sure that your investment results in solid, data-driven decisions for your healthcare business in Brazil.

Planning research in Brazil? Tell us your audience, markets and timeline, and we will come back with a feasibility check and recommended approach.

Request a quote View case studies

Frequently asked questions

What are the best healthcare market research companies in Brazil?

The best companies are those that combine local presence with deep sector expertise. Global firms like IQVIA and NielsenIQ are leaders in syndicated data, while specialized primary research firms like Global Vox Populi and BioNixus are preferred for bespoke studies involving physicians, patients, and healthcare professionals.

How does the Brazilian healthcare market research environment differ for pharma vs consumer health?

Pharma research requires high regulatory compliance, clinical depth, and access to medical specialists, often involving complex primary research. Consumer health research focuses more on retail performance, brand tracking, and large-scale consumer behavior, often using syndicated measurement tools.

Which market research agencies in Brazil have ANVISA-aware experience?

Agencies that focus on pharmaceutical research, such as Global Vox Populi and BioNixus, typically possess the regulatory knowledge required to work through ANVISA guidelines, particularly regarding adverse event reporting and data handling in primary clinical studies.

Are there global market research firms with dedicated healthcare teams in Brazil?

Yes, several global firms maintain dedicated healthcare practices in Brazil, including IQVIA, Ipsos, and Kantar. These firms provide a mix of syndicated data and specialized consulting to support the local operations of global pharmaceutical and healthcare companies.

How do I find reliable pharmaceutical market data for Brazil?

Reliable data is typically sourced from syndicated providers like IQVIA or NielsenIQ for market-wide trends. For specific commercial questions, primary research conducted by specialized firms is necessary to bridge the gaps in syndicated datasets.

What is the role of real-world evidence in Brazilian healthcare research?

Real-world evidence is increasingly used to supplement clinical trial data, helping to understand how treatments perform in the actual Brazilian healthcare system, including the Unified Health System (SUS) and private insurance settings.

How does the Unified Health System (SUS) influence market research in Brazil?

The SUS is a primary driver of healthcare access and purchasing in Brazil. Research must account for its influence on drug procurement, treatment guidelines, and the overall patient journey, as these factors significantly affect market dynamics for pharmaceutical products.

What should I look for when buying healthcare research in Brazil?

Look for firms with verified proprietary panels, strong compliance records including ISO certifications, and a clear understanding of the Brazilian regulatory environment. Prioritize providers that offer transparent feasibility reports and clear documentation of their respondent verification processes.

Request research

Let's begin

Ready to hear what your market actually thinks?

Tell us the decision you're trying to make. We'll come back with what we'd field — usually within four business hours.

Brief us on a study